{
    "id": "30511729-d20f-8726-e063-6394a90a6053",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "organization": "Chartwell RX, LLC",
    "effectiveTime": "20250314",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "chebi_id": null,
            "drugbank_id": "DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "chebi_id": null,
            "drugbank_id": "DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A",
            "code": "H8AV0SQX4D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "MECLIZINE HYDROCHLORIDE",
            "code": "HDP7W44CIO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6709"
        }
    ],
    "indications": [
        {
            "text": "1 usage meclizine hydrochloride tablet indicated treatment vertigo associated diseases affecting vestibular system adults . meclizine hydrochloride tablet indicated treatment vertigo associated diseases affecting vestibular system adults ( 1 ) .",
            "doid_id": null,
            "orphanet_id": null
        }
    ],
    "contraindications": [
        {
            "text": "4 meclizine hydrochloride tablets contraindicated patients hypersensitivity meclizine inactive ingredients [ ( 6 ) description ( 11 ) ] . meclizine hydrochloride tablets contraindicated patients hypersensitivity meclizine inactive ingredients ( 4 ) .",
            "doid_id": "http://purl.obolibrary.org/obo/DOID_1205",
            "orphanet_id": null
        }
    ],
    "warningsAndPrecautions": "5 may cause drowsiness : caution driving car operating dangerous machinery ( 5.1 ) . potential anticholinergic action : prescribed care patients history asthma , glaucoma , enlargement prostate gland ( 5.2 ) . 5.1 drowsiness since drowsiness may occur meclizine hydrochloride tablets , patients warned possibility cautioned driving car operating dangerous machinery . patients avoid alcoholic beverages taking meclizine hydrochloride tablets [ ( 7.1 ) ] . 5.2 concurrent medical conditions potential anticholinergic action , meclizine hydrochloride tablets used caution patients asthma , glaucoma , enlargement prostate gland .",
    "adverseReactions": "6 following associated meclizine hydrochloride tablets identified postmarketing reports . reported voluntarily population uncertain size , always possible reliably estimate frequency establish causal relationship exposure . anaphylactic reaction , drowsiness , dry mouth , headache , fatigue , vomiting . rare occasions blurred vision reported . common anaphylactic reaction , drowsiness , dry mouth , headache , fatigue , vomiting . rare occasions blurred vision reported ( 6 ) . report suspected , contact chartwell rx , llc 1-845-232-1683 , fda 1-800-fda-1088 . www.fda.gov/medwatch",
    "indications_original": "1 INDICATIONS AND USAGE Meclizine hydrochloride tablet is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. Meclizine hydrochloride tablet is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults ( 1 ).",
    "contraindications_original": "4 CONTRAINDICATIONS Meclizine hydrochloride tablets are contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients [see ADVERSE REACTIONS (6) and DESCRIPTION (11) ]. Meclizine hydrochloride tablets are contraindicated in patients with hypersensitivity to meclizine or any of the inactive ingredients ( 4 ).",
    "warningsAndPrecautions_original": "5 WARNINGS AND PRECAUTIONS May cause drowsiness: Use caution when driving a car or operating dangerous machinery ( 5.1 ). Potential anticholinergic action: this drug should be prescribed with care to patients with a history of asthma, glaucoma, or enlargement of the prostate gland ( 5.2 ). 5.1 Drowsiness Since drowsiness may occur with use of meclizine hydrochloride tablets, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery. Patients should avoid alcoholic beverages while taking meclizine hydrochloride tablets [see DRUG INTERACTIONS (7.1) ]. 5.2 Concurrent Medical Conditions Because of its potential anticholinergic action, meclizine hydrochloride tablets should be used with caution in patients with asthma, glaucoma, or enlargement of the prostate gland.",
    "adverseReactions_original": "6 ADVERSE REACTIONS The following adverse reactions associated with the use of meclizine hydrochloride tablets were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting. On rare occasions blurred vision has been reported. Common adverse reactions are anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting. On rare occasions blurred vision has been reported ( 6 ). To report SUSPECTED ADVERSE REACTIONS, contact Chartwell RX, LLC at 1-845-232-1683, or FDA at 1-800-FDA-1088 or . www.fda.gov/medwatch",
    "drug": [
        {
            "name": "Meclizine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6709"
        }
    ]
}